Immix Biopharma Statistics
Total Valuation
IMMX has a market cap or net worth of $54.94 million. The enterprise value is $26.72 million.
| Market Cap | 54.94M |
| Enterprise Value | 26.72M |
Important Dates
The next estimated earnings date is Friday, August 9, 2024, after market close.
| Earnings Date | Aug 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
IMMX has 26.41 million shares outstanding. The number of shares has increased by 68.65% in one year.
| Shares Outstanding | 26.41M |
| Shares Change (YoY) | +68.65% |
| Shares Change (QoQ) | +35.16% |
| Owned by Insiders (%) | 41.60% |
| Owned by Institutions (%) | 20.47% |
| Float | 13.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.97 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.82, with a Debt / Equity ratio of 0.04.
| Current Ratio | 5.82 |
| Quick Ratio | n/a |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -94.20% and return on invested capital (ROIC) is -66.22%.
| Return on Equity (ROE) | -94.20% |
| Return on Assets (ROA) | -78.90% |
| Return on Capital (ROIC) | -66.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.07M |
| Employee Count | 17 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, IMMX has paid $30,084 in taxes.
| Income Tax | 30,084 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 0.17 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 2.14 |
| 200-Day Moving Average | 3.46 |
| Relative Strength Index (RSI) | 48.40 |
| Average Volume (20 Days) | 202,743 |
Short Selling Information
The latest short interest is 557,402, so 2.11% of the outstanding shares have been sold short.
| Short Interest | 557,402 |
| Short Previous Month | 473,088 |
| Short % of Shares Out | 2.11% |
| Short % of Float | 4.17% |
| Short Ratio (days to cover) | 4.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -19.21M |
| Pretax Income | -18.18M |
| Net Income | -18.21M |
| EBITDA | -18.15M |
| EBIT | -18.18M |
| Earnings Per Share (EPS) | -$0.93 |
Balance Sheet
The company has $29.32 million in cash and $1.09 million in debt, giving a net cash position of $28.23 million or $1.07 per share.
| Cash & Cash Equivalents | 29.32M |
| Total Debt | 1.09M |
| Net Cash | 28.23M |
| Net Cash Per Share | $1.07 |
| Equity (Book Value) | 27.92M |
| Book Value Per Share | 1.06 |
| Working Capital | 27.26M |
Cash Flow
In the last 12 months, operating cash flow was -$13.11 million and capital expenditures -$315,090, giving a free cash flow of -$13.42 million.
| Operating Cash Flow | -13.11M |
| Capital Expenditures | -315,090 |
| Free Cash Flow | -13.42M |
| FCF Per Share | -$0.57 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
IMMX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -68.65% |
| Shareholder Yield | -68.65% |
| Earnings Yield | -33.14% |
| FCF Yield | -24.43% |
Analyst Forecast
The average price target for IMMX is $10.50, which is 404.81% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.50 |
| Price Target Difference | 404.81% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |